Manufacturing & Production
'' GlaxoSmithKline Facility in Dungarvan has been existence for over 27 years and employs 750 people. It is a global supply site having 70 markets throughout the world supplying bulk granulate and tablets for localised packing in other regions and also supplying finished packs to Middle East and Europe. The facility comprises of a number of production streams:
Panadol – Producing base Panadol product.
Dry Blending – Panadol Extra & Actifast
Enterprise – Solpadeine Solid Dose, Beechams and others.
Effervescent – Solpadeine Soluble
Denture Paste – Poligrip
Denture Cleanser – Polident
Over the last 2 years we have invested EUR 60M in increasing our capacity at the site. We have also recently added Nicotine Replacement Therapies – Niquitin Patches and Niquitin Mini lozenges to our portfolio investing a further EUR 46M. The facility has developed a reputation for Excellence in Key Business Drivers, delivering quality product to our consumers and creating value for our stakeholders. The business is supported by a workforce who is committed to continuously improving in all that we do. GlaxoSmithKline Dungarvan is delighted to be associated with the Dungarvan and West Waterford Chamber.